通过世界领先的临床前神经科学经验，更快地开发帕金森疾病治疗方法

在过去二十多年里，Atuka 始终致力于提供前沿的临床前研究服务，拓展帕金森病领域的科学边界，助力改变生命的创新疗法早日成为现实。

我们通过将专业的神经科学、帕金森疾病领域的经验与业界领先的啮齿类、非人灵长类动物模型和基因治疗开发经验相结合，帮助合作伙伴从临床前向临床推进时做出明智、关键的决策，从而为任何潜在疗法设计出最适合的方案。

我们为全球合作伙伴提供高质量的研究数据，由世界领先的神经科学家团队进行解读，确保研究结果具有高度的可预测性与可转化性。

Atuka概览

为患者、合作伙伴和更广泛的研发领域带来改变

Atuka 的首席科学家们在过去三十年中推动了诸多关键突破，深刻影响了帕金森病研究的发展方向。他们已共同发表逾 300 篇高影响力、经同行评审的论文，个人 h 指数在 25 至 70 之间，处于该领域的世界前列。

300+

疗法已被评估

30+

候选药物进入临床试验

300+

经同行评审的学术论文

40+

临床前动物模型

白皮书

Redefining Parkinson’s Disease

A primer on the emerging biological understanding of Parkinson’s and its possible impact on the development of novel therapeutics and disease modelling.

Biological classification and the future of therapeutics

发现系列

#2 – BDNF/TrkB

Read the latest entry in our new series on the latest research on emerging targets in Parkinson’s Disease.

The Potential of BDNF/TrkB Pathway Modulation in Parkinson’s Disease

新闻和行业见解

A quality system that boosts both research integrity and innovation
Unlike other quality systems, EQIPD has been designed to spur innovation in research without sacrificing rigor.
Better data, better reproducibility: the importance of quality systems
Patrick Howson on constantly improving Atuka’s quality system and the value of EQIPD.

Listening to patients, leading with science
A conversation with Peter DiBiaso on how patient voices can shape real progress in Parkinson’s research, moving us from token listening to actionable science.
Atuka moves into North America’s largest urban innovation hub
In a significant moment for Atuka, we have completed the move into our new offices and facilities in the MaRS Discovery District in Toronto.

WHAT OUR PARTNERS SAY

“Working with Atuka has been a highly satisfying experience! They exceeded our expectations in terms of quality, timeliness, and cost. Their knowledge and expertise in the Parkinson’s disease area were invaluable, helping us select and design in vivo models and obtain critical data to drive our projects toward success. We will definitely continue collaborating with Atuka as our program requires and recommend them to our peers without hesitation.”

– Kevin Fang, Chief Scientific Officer
Ignis Therapeutics

认识ATUKA团队

Sahar Tamadon on her passion for neuroscience

Coming from a family of engineers in Tehran, Sahar Tamadon wanted to find her own niche.

阅读全文

How a backyard mishap put Tom Johnston on his unexpected path to neuroscience

Atuka's COO went from a budding orchestral double bassist to world leading researcher in Parkinson's disease.

阅读全文

Vidya Alexander on the human brain and the endless possibilities for discovery

A deep love of lab work is a big part of what drives Atuka senior researcher Vidya Alexander, along with a fascination for the potential discoveries still hidden in the human brain.

阅读全文